401-420, Biomedical Park
4th Floor 185 South Avenue TEDA West District
Tianjin 300457
China
86 022 5821 3600
https://www.cansinotech.com
版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 1,494
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Dr. Xuefeng Yu Ph.D. | Co-Founder, Executive Chairman, CEO & GM | 無 | 無 | 1965 |
Dr. Tao Zhu Ph.D. | Co-Founder, Deputy GM, Chief Scientific Officer & Executive Director | 無 | 無 | 1974 |
Dr. Dongxu Qiu MBA, Ph.D. | Co-Founder, Executive VP, Deputy GM & Executive Director | 無 | 無 | 1961 |
Dr. Shou-Bai Chao Ph.D. | COO, Deputy GM & Executive Director | 無 | 無 | 1964 |
Ms. Jing Wang | Chief Commercial Officer, Deputy GM & Executive Director | 無 | 無 | 1981 |
Mr. Chunlin Xin | Senior Director of New Technology Department | 無 | 無 | 無 |
Mr. Yonghui Wu | Vice President of Marketing | 無 | 無 | 無 |
Mr. Jin Cui | Board Secretary | 無 | 無 | 1987 |
Mr. Ming King Chiu FCIS, FCS | Joint Company Secretary | 無 | 無 | 1977 |
康希諾的使命是研發、生產和商業化高質量、創新及經濟實惠的疫苗。
截至 2024年4月1日 止,康希諾生物 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中:3;董事會:3;股東權利:9;現金賠償:3。